DekaBank Deutsche Girozentrale’s Harmony Biosciences HRMY Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60K	Hold	2,182	–	–	﹤0.01%	1059
2026 Q1	$62K	Hold	2,182	–	–	﹤0.01%	1061
2025 Q4	$77K	Hold	2,182	–	–	﹤0.01%	1281
2025 Q3	$76K	Hold	2,182	–	–	﹤0.01%	1264
2025 Q2	$77K	Hold	2,182	–	–	﹤0.01%	1260
2025 Q1	$74K	Hold	2,182	–	–	﹤0.01%	1252
2024 Q4	$67K	Hold	2,182	–	–	﹤0.01%	1310
2024 Q3	$70K	Hold	2,182	–	–	﹤0.01%	1322
2024 Q2	$68K	Hold	2,182	–	–	﹤0.01%	1342
2024 Q1	$74K	Hold	2,182	–	–	﹤0.01%	1305
2023 Q4	$71K	Hold	2,182	–	–	﹤0.01%	1364
2023 Q3	$73K	Sell	2,182 -3,004	-58%	-$104K	﹤0.01%	1342
2023 Q2	$183K	Sell	5,186 -20,000	-79%	-$690K	﹤0.01%	1173
2023 Q1	$823K	Sell	25,186 -10,000	-28%	-$455K	﹤0.01%	915
2022 Q4	$1.94M	Hold	35,186	–	–	0.01%	729
2022 Q3	$1.55M	Buy	35,186 +26,686	+314%	+$1.3M	﹤0.01%	771
2022 Q2	$429K	Sell	8,500 -30,000	-78%	-$1.35M	﹤0.01%	1045
2022 Q1	$1.92M	Buy	38,500 +3,500	+10%	+$143K	﹤0.01%	762
2021 Q4	$1.52M	Buy	+35,000	New	+$1.4M	﹤0.01%	841

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

DekaBank Deutsche Girozentrale's HRMY Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 2,182 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #1059.

DekaBank Deutsche Girozentrale first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.94M in Q4 2022. 131 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

DekaBank Deutsche Girozentrale held 2,182 shares of Harmony Biosciences worth $60K as of Q2 2026.
DekaBank Deutsche Girozentrale left its Harmony Biosciences share count unchanged in Q2 2026.
Harmony Biosciences made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #1059 holding.
DekaBank Deutsche Girozentrale first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
DekaBank Deutsche Girozentrale's Harmony Biosciences position peaked at $1.94M in Q4 2022.
131 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.